CSL Behring
CSL Behring is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.
About CSL Behring
CSL Behring is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by ETRANACOGENE DEZAPARVOVEC. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: treatment adults, hemophilia congenital, factor deficiency, prophylaxis therapy, current historical, life-threatening hemorrhage, repeated serious, spontaneous bleeding. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| ETRANACOGENE DEZAPARVOVEC | 1 |
FDA drug products from CSL Behring
| Brand name | Generic | Type | Route |
|---|---|---|---|
| HEMGENIX | ETRANACOGENE DEZAPARVOVEC | HUMAN PRESCRIPTION DRUG |
Frequently asked questions
How many FDA drug products does CSL Behring make?
1 FDA drug label records name CSL Behring as the manufacturer, covering 1 distinct active ingredients.
What active ingredients does CSL Behring produce?
The most frequent active ingredients in this portfolio are ETRANACOGENE DEZAPARVOVEC.
Are CSL Behring products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.